Abstract
Cancer cells differ from the other cells by their ability to survive under conditions of enhanced oxidative stress. This property of cancer cells might also be an origin of resistance of tumors to drug treatment. Reactive oxygen species (ROS) overproduction (oxidative stress) might be responsible for both survival and death of cancer cells and the opposite effects of ROS signaling can depend on many reasons. In present work we consider several possible mechanisms of ROS effects on survival/death cancer cells: the different effects of two main reactive oxygen species paramagnetic free radical anion superoxide and diamagnetic molecule hydrogen peroxide, competition between protein kinases and phosphatases, and modification of ROS-depended enzyme/gene cascades. The oxidation of protein kinase B (Akt) by ROS might be of great importance for a shift of the survival to apoptotic signal in the enzymatic cascade. Dual effects of ROS overproduction on cancer cells appear to depend on the levels of oxidative stress: weak/ moderate oxidative stress enhances survival while severe oxidative stress induces cell death. The regulation of ROS overproduction by antioxidants and prooxidants is possibly an important promising way for cancer treatment.
Keywords: ROS signaling, cancer, survival, apoptosis, diabetes mellitus, N-acetylcysteine, deetherification, deprotonation, glycolysis, cytochrome-cardiolipi
Current Signal Transduction Therapy
Title:Enhanced Free Radical Status of Cancer Cells Success and Failure of Prooxidant/Antioxidant Treatment
Volume: 7 Issue: 3
Author(s): Igor Afanas'ev
Affiliation:
Keywords: ROS signaling, cancer, survival, apoptosis, diabetes mellitus, N-acetylcysteine, deetherification, deprotonation, glycolysis, cytochrome-cardiolipi
Abstract: Cancer cells differ from the other cells by their ability to survive under conditions of enhanced oxidative stress. This property of cancer cells might also be an origin of resistance of tumors to drug treatment. Reactive oxygen species (ROS) overproduction (oxidative stress) might be responsible for both survival and death of cancer cells and the opposite effects of ROS signaling can depend on many reasons. In present work we consider several possible mechanisms of ROS effects on survival/death cancer cells: the different effects of two main reactive oxygen species paramagnetic free radical anion superoxide and diamagnetic molecule hydrogen peroxide, competition between protein kinases and phosphatases, and modification of ROS-depended enzyme/gene cascades. The oxidation of protein kinase B (Akt) by ROS might be of great importance for a shift of the survival to apoptotic signal in the enzymatic cascade. Dual effects of ROS overproduction on cancer cells appear to depend on the levels of oxidative stress: weak/ moderate oxidative stress enhances survival while severe oxidative stress induces cell death. The regulation of ROS overproduction by antioxidants and prooxidants is possibly an important promising way for cancer treatment.
Export Options
About this article
Cite this article as:
Afanas'ev Igor, Enhanced Free Radical Status of Cancer Cells Success and Failure of Prooxidant/Antioxidant Treatment, Current Signal Transduction Therapy 2012; 7 (3) . https://dx.doi.org/10.2174/157436212802481637
DOI https://dx.doi.org/10.2174/157436212802481637 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cancer Drug Discovery Targeting Histone Methyltransferases: An Update
Current Medicinal Chemistry A Review of the Current Role of Proton Therapy in Modern Oncology
Current Drug Therapy Prognostic and Predictive Biomarkers in Cancer
Current Cancer Drug Targets Potential Association Between TLR4 and Chitinase 3-Like 1 (CHI3L1/YKL-40) Signaling on Colonic Epithelial Cells in Inflammatory Bowel Disease and Colitis-Associated Cancer
Current Molecular Medicine Flavonoids as Multi-Target Compounds in Drug Discovery
Mini-Reviews in Organic Chemistry MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells
Current Cancer Drug Targets Profiling of Enzymatic Activities Using Peptide Arrays
Mini-Reviews in Organic Chemistry Mesenchymal Stem Cells in Cartilage Repair: State of the Art and Methods to monitor Cell Growth, Differentiation and Cartilage Regeneration
Current Medicinal Chemistry Evolution of Mannose 6-Phosphate Receptors (MPR300 and 46): Lysosomal Enzyme Sorting Proteins
Current Protein & Peptide Science Resveratrol as an Enhancer of Apoptosis in Cancer: A Mechanistic Review
Anti-Cancer Agents in Medicinal Chemistry Glucosamine Sulphate in Osteoarthritis: From Symptoms to Structure Modification
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Functions of Histone Modification Enzymes in Cancer
Current Protein & Peptide Science Small-molecule Inhibitors of Epigenetic Mutations as Compelling Drugtargets for Myelodysplastic Syndromes
Current Cancer Drug Targets Metabolism and Structure-Function Relationships of Connective Tissue Glycosaminoglycans and Proteoglycans
Current Organic Chemistry miRNAs in Melanoma: Tumor Suppressors and Oncogenes with Prognostic Potential
Current Medicinal Chemistry Molecular and Cellular Regulators of Cancer Angiogenesis
Current Cancer Drug Targets Discovery of Hedgehog Antagonists for Cancer Therapy
Current Medicinal Chemistry The Role of miR-129-5p in Cancer: A Novel Therapeutic Target
Current Molecular Pharmacology CXCR4 and Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Heparin, Heparan Sulfate and Heparanase in Cancer: Remedy for Metastasis?
Anti-Cancer Agents in Medicinal Chemistry